{"id":157757,"date":"2021-11-19T19:31:13","date_gmt":"2021-11-19T17:31:13","guid":{"rendered":"https:\/\/www.btv.md\/?p=157757"},"modified":"2021-11-19T19:31:13","modified_gmt":"2021-11-19T17:31:13","slug":"ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova","status":"publish","type":"post","link":"https:\/\/www.btv.md\/ro\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/","title":{"rendered":"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova"},"content":{"rendered":"<p><strong>Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19, scrie <a href=\"https:\/\/www.zdg.md\/stiri\/stiri-externe\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/\">ziarul de gard\u0103.<\/a><\/strong><\/p>\n<p>Medicamentul, care \u00een prezent nu este autorizat \u00een UE, poate fi utilizat pentru a trata adul\u021bii cu COVID-19 care nu necesit\u0103 oxigen suplimentar \u0219i care prezint\u0103 un risc crescut de a dezvolta o form\u0103 sever\u0103 de COVID-19. Lagevrio trebuie administrat c\u00e2t mai cur\u00e2nd posibil dup\u0103 diagnosticarea cu COVID-19 \u0219i \u00een termen de cinci zile de la debutul simptomelor.\u00a0Medicamentul, care este disponibil sub form\u0103 de capsule, trebuie luat de dou\u0103 ori pe zi timp de cinci zile.<\/p>\n<p>EMA a emis acest sfat pentru a sprijini autorit\u0103\u021bile na\u021bionale care pot decide cu privire la o posibil\u0103 utilizare timpurie a medicamentului, \u00eenainte de autorizarea de introducere pe pia\u021b\u0103,\u00a0de exemplu \u00een situa\u021bii de utilizare de urgen\u021b\u0103.<\/p>\n<blockquote><p><em>Lagevrio, administrat \u00een doz\u0103 de 800 mg de dou\u0103 ori pe zi, a redus riscul de spitalizare \u0219i deces atunci c\u00e2nd tratamentul a \u00eenceput \u00een decurs de cinci zile de la debutul simptomelor.\u00a0La aproximativ o lun\u0103 dup\u0103 \u00eenceperea tratamentului, 7,3% dintre pacien\u021bii (28 din 385) care au luat Lagevrio, comparativ cu 14,1% (53 din 377) dintre pacien\u021bii c\u0103rora li s-a administrat placebo (un tratament inactiv) fuseser\u0103 spitaliza\u021bi sau au murit;\u00a0niciunul dintre pacien\u021bii din grupul Lagevrio nu a murit \u00een compara\u021bie cu opt pacien\u021bi din grupul placebo.<\/em><\/p><\/blockquote>\n<p>\u00cen ceea ce prive\u0219te siguran\u021ba, cele mai frecvente reac\u021bii adverse raportate \u00een timpul tratamentului \u0219i \u00een decurs de 14 zile dup\u0103 ultima doz\u0103 de Lagevrio au fost diaree, grea\u021b\u0103, ame\u021beli \u0219i dureri de cap, toate fiind fie u\u0219oare, fie moderate.<\/p>\n<blockquote class=\"wp-block-quote\"><p><em>Lagevrio nu este recomandat \u00een timpul sarcinii \u0219i la femeile care pot r\u0103m\u00e2ne \u00eens\u0103rcinate \u0219i nu utilizeaz\u0103 metode contraceptive eficiente.\u00a0Femeile care pot r\u0103m\u00e2ne \u00eens\u0103rcinate trebuie s\u0103 utilizeze metode contraceptive eficiente \u00een timpul tratamentului \u0219i timp de 4 zile dup\u0103 ultima doz\u0103 de Lagevrio.\u00a0Al\u0103ptarea trebuie \u00eentrerupt\u0103 \u00een timpul tratamentului \u0219i timp de 4 zile dup\u0103 tratament.\u00a0<\/em><\/p><\/blockquote>\n<p>Aceste recomand\u0103ri sunt date deoarece studiile de laborator la animale au ar\u0103tat c\u0103 dozele mari de Lagevrio pot avea un impact asupra cre\u0219terii \u0219i dezvolt\u0103rii f\u0103tului, noteaz\u0103 EMA.<\/p>\n<p>O revizuire continu\u0103, mai cuprinz\u0103toare, este \u00een curs de desf\u0103\u0219urare \u00eenaintea unei posibile cereri pentru o autoriza\u021bie de introducere pe pia\u021b\u0103.<\/p>\n<p>Agen\u021bia Medicamentului \u0219i Dispozitivelor Medicale (AMDM) a aprobat, \u00een cadrul \u0219edin\u021bei de luni, 15 noiembrie curent, a Comisiei pentru autorizarea importului produselor farmaceutice neautorizate \u00een R. Moldova, importul pentru produsul medicamentos cu con\u021binut de\u00a0Molnupiravir, capsule 200 mg N4x10.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19, scrie ziarul de gard\u0103. Medicamentul, care \u00een prezent nu este autorizat \u00een UE, poate fi utilizat pentru a trata adul\u021bii cu COVID-19 care nu necesit\u0103 [&hellip;]<\/p>\n","protected":false},"author":26,"featured_media":157759,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34198],"tags":[34463,34459,34460,8108,8085,34462,34461],"class_list":["post-157757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sanatate","tag-autorizarea","tag-ema","tag-emis","tag-import","tag-medicamente-ro","tag-tratamentul-covid-19","tag-utilizarea-lagevrio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV<\/title>\n<meta name=\"description\" content=\"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV\" \/>\n<meta property=\"og:description\" content=\"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/\" \/>\n<meta property=\"og:site_name\" content=\"BTV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/btvmoldova\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-19T17:31:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1020\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Victoria Ursu\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Victoria Ursu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/\"},\"author\":{\"name\":\"Victoria Ursu\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/#\\\/schema\\\/person\\\/e4b592cd4d0aac4a25b0ac526c4c341f\"},\"headline\":\"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova\",\"datePublished\":\"2021-11-19T17:31:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/\"},\"wordCount\":467,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.btv.md\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lage-1920x1020-c-default.png\",\"keywords\":[\"autorizarea\",\"EMA\",\"emis\",\"import\",\"medicamente\",\"tratamentul COVID-19\",\"utilizarea Lagevrio\"],\"articleSection\":[\"S\u0103n\u0103tate\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/\",\"url\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/\",\"name\":\"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.btv.md\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lage-1920x1020-c-default.png\",\"datePublished\":\"2021-11-19T17:31:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.btv.md\\\/#\\\/schema\\\/person\\\/e4b592cd4d0aac4a25b0ac526c4c341f\"},\"description\":\"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19\",\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/ro\\\/amp\\\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.btv.md\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lage-1920x1020-c-default.png\",\"contentUrl\":\"https:\\\/\\\/www.btv.md\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lage-1920x1020-c-default.png\",\"width\":1920,\"height\":1020,\"caption\":\"Lagevrio este un medicament antiviral oral care reduce capacitatea SARS-CoV-2 de a se multiplica \u00een organism. Foto: Ziarul de Gard\u0103\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/#website\",\"url\":\"https:\\\/\\\/www.btv.md\\\/\",\"name\":\"BTV\",\"description\":\"\u0411\u0435\u043b\u044c\u0446\u043a\u043e\u0435 \u0442\u0435\u043b\u0435\u0432\u0438\u0434\u0435\u043d\u0438\u0435\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.btv.md\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.btv.md\\\/#\\\/schema\\\/person\\\/e4b592cd4d0aac4a25b0ac526c4c341f\",\"name\":\"Victoria Ursu\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV","description":"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/","og_locale":"ro_RO","og_type":"article","og_title":"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV","og_description":"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19","og_url":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/","og_site_name":"BTV","article_publisher":"https:\/\/www.facebook.com\/btvmoldova\/","article_published_time":"2021-11-19T17:31:13+00:00","og_image":[{"width":1920,"height":1020,"url":"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png","type":"image\/png"}],"author":"Victoria Ursu","twitter_misc":{"Scris de":"Victoria Ursu","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#article","isPartOf":{"@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/"},"author":{"name":"Victoria Ursu","@id":"https:\/\/www.btv.md\/#\/schema\/person\/e4b592cd4d0aac4a25b0ac526c4c341f"},"headline":"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova","datePublished":"2021-11-19T17:31:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/"},"wordCount":467,"commentCount":0,"image":{"@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#primaryimage"},"thumbnailUrl":"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png","keywords":["autorizarea","EMA","emis","import","medicamente","tratamentul COVID-19","utilizarea Lagevrio"],"articleSection":["S\u0103n\u0103tate"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/","url":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/","name":"EMA a emis sfaturi privind utilizarea medicamentului, pentru tratamentul COVID-19, importul c\u0103ruia a fost autorizat de R. Moldova - BTV","isPartOf":{"@id":"https:\/\/www.btv.md\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#primaryimage"},"image":{"@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#primaryimage"},"thumbnailUrl":"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png","datePublished":"2021-11-19T17:31:13+00:00","author":{"@id":"https:\/\/www.btv.md\/#\/schema\/person\/e4b592cd4d0aac4a25b0ac526c4c341f"},"description":"Comitetul pentru medicamente de uz uman\u00a0 al\u00a0Agen\u021biei Europene pentru Medicamente a emis un aviz cu privire la utilizarea Lagevrio, cunoscut \u0219i ca molnupiravir sau MK 4482, medicament pentru tratamentul COVID-19","inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.btv.md\/ro\/amp\/ema-a-emis-sfaturi-privind-utilizarea-medicamentului-pentru-tratamentul-covid-19-importul-caruia-a-fost-autorizat-de-r-moldova\/#primaryimage","url":"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png","contentUrl":"https:\/\/www.btv.md\/wp-content\/uploads\/2021\/11\/lage-1920x1020-c-default.png","width":1920,"height":1020,"caption":"Lagevrio este un medicament antiviral oral care reduce capacitatea SARS-CoV-2 de a se multiplica \u00een organism. Foto: Ziarul de Gard\u0103"},{"@type":"WebSite","@id":"https:\/\/www.btv.md\/#website","url":"https:\/\/www.btv.md\/","name":"BTV","description":"\u0411\u0435\u043b\u044c\u0446\u043a\u043e\u0435 \u0442\u0435\u043b\u0435\u0432\u0438\u0434\u0435\u043d\u0438\u0435","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.btv.md\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/www.btv.md\/#\/schema\/person\/e4b592cd4d0aac4a25b0ac526c4c341f","name":"Victoria Ursu"}]}},"_links":{"self":[{"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/posts\/157757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/comments?post=157757"}],"version-history":[{"count":0,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/posts\/157757\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/media\/157759"}],"wp:attachment":[{"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/media?parent=157757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/categories?post=157757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btv.md\/ro\/wp-json\/wp\/v2\/tags?post=157757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}